These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tamoxifen/norfloxacin interaction leading to QT interval prolongation in a female patient with extracranial meningioma. Slovacek L; Priester P; Petera J; Slanska I; Kopecky J Bratisl Lek Listy; 2011; 112(6):353-4. PubMed ID: 21692412 [TBL] [Abstract][Full Text] [Related]
3. Sibutramine-associated QT interval prolongation and cardiac arrest. Ernest D; Gershenzon A; Corallo CE; Nagappan R Ann Pharmacother; 2008 Oct; 42(10):1514-7. PubMed ID: 18728104 [TBL] [Abstract][Full Text] [Related]
4. Administration of tamoxifen in the perioperative period to patients with breast carcinoma prolongs axillary fluid drainage. Kelessis NG; Vassilopoulos PP; Galanopoulou AV; Nessiotis AG; Stravolemos CM Anticancer Res; 2000; 20(2B):1245-8. PubMed ID: 10810428 [TBL] [Abstract][Full Text] [Related]
5. A breast cancer patient with myelodysplastic syndrome postoperatively treated by radiation and tamoxifen administration--a case report. Mitani N; Sakuragi S; Matsuda K; Tanaka Y; Matsui K; Shinohara K Gan To Kagaku Ryoho; 2006 Jun; 33(6):833-6. PubMed ID: 16770108 [TBL] [Abstract][Full Text] [Related]
6. Endometrial carcinoma following treatment for breast carcinoma in a Nigerian female. A case report and review of the literature. Abudu EK; Musa O; Adefuye PO; Abdul Kareem FB; Agboola AO; Banjo AA Niger Postgrad Med J; 2007 Dec; 14(4):355-7. PubMed ID: 18163149 [TBL] [Abstract][Full Text] [Related]
7. A case report of QT prolongation with glycopyrronium bromide in a patient with chronic tamoxifen use. Chiu MH; Al-Majed NS; Stubbins R; Pollmann D; Sandhu RK BMC Res Notes; 2016 Jun; 9():310. PubMed ID: 27301406 [TBL] [Abstract][Full Text] [Related]
8. Interaction between warfarin and tamoxifen: a case report. Mishra D; Paudel R; Kishore PV; Palaian S; Bista D; Misra P Kathmandu Univ Med J (KUMJ); 2007; 5(1):105-7. PubMed ID: 18603996 [TBL] [Abstract][Full Text] [Related]
9. Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer. Ebert AD; Rosenow G; David M; Mechsner S; Magalov IS; Papadopoulos T Gynecol Obstet Invest; 2008; 66(3):209-13. PubMed ID: 18645252 [TBL] [Abstract][Full Text] [Related]
10. [Factors predicting failure of adjuvant hormonotherapy of breast carcinoma. A study in tamoxifen treated patients]. Petráková K; Nenutil R; Grell P; Fabian P; Zichová I; Svoboda M; Palácová M; Vyzula R Klin Onkol; 2008; 21(5):303-8. PubMed ID: 19202962 [TBL] [Abstract][Full Text] [Related]
11. The clinical significance of QT prolongation associated with tamoxifen: A review of the literature. Fung K; Imeson J; Cusano F J Oncol Pharm Pract; 2018 Oct; 24(7):525-530. PubMed ID: 28728494 [TBL] [Abstract][Full Text] [Related]
12. Axillary lymph node metastases as the sole clinical site of occult breast carcinoma. Dragoumis DM; Tsiftsoglou AP; Sikou AD; Assimaki AS J Coll Physicians Surg Pak; 2008 Aug; 18(8):517-9. PubMed ID: 18798593 [TBL] [Abstract][Full Text] [Related]
13. Bepridil produces prominent bradycardia-dependent QT prolongation in patients with structural heart disease. Sadanaga T; Ogawa S J Electrocardiol; 2007; 40(5):426-31. PubMed ID: 17531251 [TBL] [Abstract][Full Text] [Related]
14. Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism: a Danish population-based cohort study. Hernandez RK; Sørensen HT; Pedersen L; Jacobsen J; Lash TL Cancer; 2009 Oct; 115(19):4442-9. PubMed ID: 19569248 [TBL] [Abstract][Full Text] [Related]